A growing number of concerned Americans are demanding hospital Ivermectin treatment for COVID. This week, a Michigan activist contacted me about a formal request letter to their local hospital. This is my response.
Ivermectin’s strength: preventive and early treatment
Ivermectin should be made readily available because it works, and because people have the moral right to try based on the right of self-protection. Its efficacy and safety have been verified both anecdotally and in worldwide studies.
However, hospitals are not designed for preventive and early treatment – nor should they be. Trying to force them into this role violates the few private entity rights they still have in our federalized system. It would also distort the very nature of intensive care.
Hospital clinicians who care for the very sick and injured are drowning in work. A mandate to treat the mildly ill would waste their time and skills. In addition, it would displace the proper work of primary/urgent care and independent clinicians.
Worst of all, government COVID dollars have force. Redirecting hospitals to primary care services would open both levels of care to even more government interference.
POLICY GOAL #1:
Maximize Ivermectin’s strengths with local access to preventive and early treatment.
Pass state legislation to remove state barriers to local access of Ivermectin. Bill options below can work together or separately.
1. Remove Ivermectin prescription requirements. Making it over the counter opens access to the general public, saving us time with the doctor’s office. Expect added benefits of a price drop, saving the public money at the pharmacy as well.
2. Change Michigan Licensing law to limit Licensing Boards to disciplining prescribers only after proving harm. This reduces opportunity for political manipulation.
Ivermectin’s weakness: Late Treatment
Ivermectin Late Treatment is not clearly defined in the IVMmeta study that many advocates cite.
Did treatment qualify as “Late” if it began on Day 3 of symptoms? Day 8? Day 20?
Reading more deeply in the Late Treatment description, the latest start I found was Day 12. This single study had other flaws and was placed in their exclusionary group.
The problem: COVID patients are admitted after Week 3 of symptoms – Day 21+.
Many people are sick over a month before “giving up and going in.” This meta study does not address the typical hospital COVID patient clearly, if at all.
For context, the recovery rate for COVID in the broad population is >99%. The study states that treatment allowed over 99% of people to avoid ventilator, severe symptoms, or death. A better way to state results: early treatment allowed most to avoid the hospital entirely.
In addition to early treatment success, people know their own symptoms and results best. When an endemic disease has safe treatment, it’s common sense to self-treat and avoid hospitals.
However, once home and outpatient treatment has failed, it’s time to admit it and try something else.
People normally do this when they go to the hospital for care. Unless under the influence or mentally ill, patients rarely enter the hospital with antagonism – except for COVID.
After reviewing the meta-study, I find zero persuasive, nonpolitical evidence that Ivermectin helps inpatient treatment. Unless Ivermectin acquires better support for Day 14+ late treatment, the whole “Hospitals should give it” narrative stands exposed as a political agitation stunt.
Even in a political year, no decent person would participate in political stunts that put people’s lives at risk. Destroying essential local foundations of trust is immoral and unethical. It serves death rather than life.
Policy GOAL #2:
Restore the foundations of local trust using smart strategy for hospital Ivermectin treatment.
First, ask your local hospital to help free up early access to Ivermectin – Policy GOAL #1. Most hospitals have a professional team to lobby the state legislature.
Approach your hospital with these talking points:
- Hospital admission staff need to be able to ask patients, “Have you had early treatment?”
- Knowing legal early treatment is locally available sets community expectations of personal responsibility for health, lifting the hospital burden.
- A culture of openness is essential for staff to get direct, honest answers about early treatment for patient records.
As a patient, you need to know that information you give during admission will direct your care. You can reasonably expect that your care will only be as accurate as the information you give.
Families can restore trust and support hospitalized loved ones with these tips.
Finally, ask the hospital to incorporate Right to Try for Ivermectin.
The best argument for hospital Ivermectin treatment is Right to Try as a gesture of good faith to restore trust between hospitals and community. Hospitals should develop their own protocol, with their own safeguards, to be available on request for ER/inpatients.
Note: Accurate human dosing is available by tablet, not IV. Yet another reason to take Ivermectin early. When you’re gasping for breath is no time to try to swallow tablets.
In conclusion, having accessible local Ivermectin and a “Right to Try” protocol available will remove some politics from the bedside. Defusing tensions over local hospital Ivermectin treatment benefits both hospital and community.